By North Raleigh Today |
Mar 29, 2025
A clinical trial led by researchers at the UNC School of Medicine has revealed significant cardiovascular benefits of oral semaglutide for individuals with type 2 diabetes, existing cardiovascular disease, or chronic kidney disease.